Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Third Trimester of Pregnancy

NCT05669963 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05669963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05669963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Third Trimester of Pregnancy
Lead sponsor
Zagazig University
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 1, 2022
Completion date
January 31, 2023
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis | vaginal | microbiology